EN IT

Recursion Pharmaceuticals, Inc. (RXRX) stocks — Weekly technical analysis | 7-11 Sep 2026

RXRX
Recursion Pharmaceuticals, Inc. Class A
Technical analysis updated on: 2026-09-12 · [ 7-11 Sep 2026 ] - Copyright AiTrading67.com
📅 Earnings · Nov 11, 2026 · in 60d
Stock · US
Inside composite NTZ, transitioning bias

Weekly technical analysis of Recursion Pharmaceuticals, Inc. (RXRX) stocks: IQS 26/100. Structure, momentum and trading levels for swing trading updated 11 Sep 2026.

SCORE IQS Lite
26/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 15
Daily Momentum 5
Weekly Ichimoku 0
Daily CMF 6
Delta 0
IQS Lite components · score
STRUCTURE15/30MOMENTUM5/35ICHIMOKU0/19CMF6/6DELTA0/10

IQS Lite analysis - AiTrading67.com · Recursion Pharmaceuticals, Inc. Class A (RXRX · ISIN US75629V1044)

Weekly Structure
At 15/30 structure is developing: moving averages only partly aligned, trend unconfirmed.
Daily Momentum
At 5/35 momentum is absent: flat or negative daily impulse, no acceleration.
Weekly Ichimoku
At 0/19 Ichimoku is fully bearish: price below the cloud, Tenkan and Kijun unsupportive.
Daily CMF
At 6/6 CMF shows inflows: capital entering and buying pressure.
Delta
At 0/10 the week is sharply down: weekly performance below -2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
Price consolidates within a neutral compression zone, balancing mixed daily-to-weekly dynamics. Weekly MACD shows sustained strength while daily momentum exhibits fading, signaling caution at current levels. Awaiting clear confirmation on either side remains the prudent approach, with structure intact but directional conviction still building.
This week's view by AiTrading67.com
Following the weekly decline, RXRX consolidates within the neutral zone in a structural compression context. Awaiting confirmation is paramount for operational validation, while IQS 26 reflects a compressed phase with inherent expansion potential. Specific directional signals will prove decisive for the next trading sequence.

Chart Recursion Pharmaceuticals, Inc. (RXRX) · 12-month trend

Over the past week the stock shed 11.8%; over twelve months it is down 34.8%.
Weekly Structure
Weekly RSI
Neutral
Weekly MACD · Status
B — Bullish but slowing
Positive histogram contracting
Weekly EMA50
Free
Price well separated from the weekly MA
Weekly EMA Stack
Full bearish stack
5/5 MAs bearish-aligned
Below CloudT-K-
In summary

Weekly RSI remains in neutral zone without extremes. MACD is in Bullish fading, showing loss of upside momentum. Weekly EMA50 stays free from compression. All moving averages maintain full bearish alignment. Ichimoku positions below the bearish cloud, confirming a technical backdrop unfavorable to rallies.

Daily Momentum
Daily ADX / DMI
Absent
−DI dominates +DI
Daily RSI
Neutral
Capital Flow (CMF)
Inflow
Daily MACD · Status
C — Early deterioration
Daily Stochastic
Oversold
Weekly EMA Cross
Mature Death Cross
In summary

Daily ADX is absent with -DI above +DI, confirming directional weakness. RSI remains in neutral zone. CMF displays strong inflows, suggesting accumulation underway. Daily MACD is in Bearish fading, showing that downside momentum is losing traction. Stochastic sits in oversold territory, signaling potential technical bounce. The moving average cross (Death Cross) on the daily is mature and confirmed.


Read the full in-depth analysis ★ GOLD
Gold membership unlocks the No-Trade Zone, weekly supports and resistances, the action plan with bull/bear probabilities and the weekly setup with entry, stop and targets — updated every week.
Join Gold →
Share WhatsApp Telegram Gmail LinkedIn